| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |